Drug recall · January 14, 2026
Fesoterodine Fumarate recall
Why: Failed Impurities/Degradation Specifications: Due to levels of 'Diester Impurity' exceeding the specification limit.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Fesoterodine Fumarate, Extended-release Tablets, 8 mg, 30 Tablets, Rx only, Manufactured by: Alembic Pharmaceuticals Limited, Panelav 389350, Gujarat, India, Manufactured for: Alembic Pharmaceuticals, Inc., Bedminster, NJ 07921, USA, NDC 62332-176-30
- Lots / codes
Lot# 2405003360, Exp Date: Jan 31, 2026
- Company
- Alembic Pharmaceuticals Limited, Panchmahal
- Distribution
- US Nationwide and PR.
- Initiated
- December 16, 2025 · Voluntary: Firm initiated
- Classified
- January 2, 2026
- Reported
- January 14, 2026
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Fesoterodine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.